Convalescent plasma for COVID-19 - encouraging signals of efficacy

Br J Haematol. 2021 Feb;192(4):681-682. doi: 10.1111/bjh.17270. Epub 2021 Feb 1.

Authors

Arturo Casadevall¹, Aaron A R Tobian²

Affiliations

¹ W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
² Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

No abstract available

Keywords: COVID-19; SARS-Cov-2; antibody; convalescent plasma.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

COVID-19 / blood
COVID-19 / therapy*
COVID-19 Serotherapy
Humans
Immunization, Passive
SARS-CoV-2 / metabolism*

Grants and funding